Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.630 | 0.680 | 3 | 52222681 | synonymous variant | C/A;G;T | snv | 2.0E-05; 0.49 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||||
|
0.630 | 0.680 | 3 | 52222681 | synonymous variant | C/A;G;T | snv | 2.0E-05; 0.49 |
|
Infections; Immune System Diseases | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||||
|
0.630 | 0.680 | 3 | 52222681 | synonymous variant | C/A;G;T | snv | 2.0E-05; 0.49 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||||
|
0.630 | 0.680 | 3 | 52222681 | synonymous variant | C/A;G;T | snv | 2.0E-05; 0.49 |
|
Digestive System Diseases; Infections | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||||
|
0.630 | 0.680 | 3 | 52222681 | synonymous variant | C/A;G;T | snv | 2.0E-05; 0.49 |
|
Infections | 0.020 | 0.500 | 2 | 2016 | 2017 | |||||||
|
0.630 | 0.680 | 3 | 52222681 | synonymous variant | C/A;G;T | snv | 2.0E-05; 0.49 |
|
Digestive System Diseases | 0.020 | 1.000 | 2 | 2009 | 2019 | |||||||
|
0.630 | 0.680 | 3 | 52222681 | synonymous variant | C/A;G;T | snv | 2.0E-05; 0.49 |
|
Infections; Nervous System Diseases | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||||
|
0.658 | 0.440 | 3 | 52226766 | intron variant | A/G | snv | 0.20 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||||
|
0.658 | 0.440 | 3 | 52226766 | intron variant | A/G | snv | 0.20 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||||
|
0.658 | 0.440 | 3 | 52226766 | intron variant | A/G | snv | 0.20 |
|
Digestive System Diseases | 0.020 | 1.000 | 2 | 2009 | 2011 | |||||||
|
0.882 | 0.120 | 3 | 52223085 | missense variant | A/G | snv | 4.0E-06 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.120 | 3 | 52223085 | missense variant | A/G | snv | 4.0E-06 |
|
Infections | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.120 | 3 | 52223085 | missense variant | A/G | snv | 4.0E-06 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.120 | 3 | 52223085 | missense variant | A/G | snv | 4.0E-06 |
|
Infections | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.120 | 3 | 52223085 | missense variant | A/G | snv | 4.0E-06 |
|
Infections; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |